Explore All Access
Check if your research matches the topics covered in Nucleic Acid Therapeutics?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Nucleic Acid Therapeutics : Impact Factor & More
eISSN: 2159-3345pISSN: 2159-3337
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Nucleic Acid Therapeutics Key Metrics
CiteScore 
9.3
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Genetics
SNIP
1.19
Topics Covered on Nucleic Acid Therapeutics
Oligonucleotide
RNA interference
RNA editing
Guide RNA
Exon
Amyloid precursor protein
Antisense oligonucleotides
Minicircle dna
Serum protein
Duchenne muscular dystrophy
Exon skipping
DNA Aptamers
Antisense RNA
Amyloid angiopathy
Type 2 diabetes
Protein splicing
G-quadruplex
RNA Aptamers
Ribosomal protein
Nucleic Acid Therapeutics Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Nucleic Acid Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Nucleic Acid Therapeutics
Modulation of Gene Expression in the Eye with Antisense Oligonucleotides.
- 2 Nov 2023
- Nucleic acid therapeutics
Systematic Analysis of Chemical Modifications of Phosphorothioate Antisense Oligonucleotides that Modulate Their Innate Immune Response
- 1 Apr 2023
- Nucleic Acid Therapeutics
Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat.
- 22 Feb 2023
- Nucleic acid therapeutics
Chemical Modifications and Design Influence the Potency of Huntingtin Anti-Gene Oligonucleotides.
- 3 Feb 2023
- Nucleic acid therapeutics
Acknowledgment of Reviewers 2022
- 1 Feb 2023
- Nucleic Acid Therapeutics
Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.
- 28 Dec 2022
- Nucleic acid therapeutics
Modulation of Gene Expression in the Eye with Antisense Oligonucleotides.
- 2 Nov 2023
- Nucleic acid therapeutics
Systematic Analysis of Chemical Modifications of Phosphorothioate Antisense Oligonucleotides that Modulate Their Innate Immune Response
- 1 Apr 2023
- Nucleic Acid Therapeutics
Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat.
- 22 Feb 2023
- Nucleic acid therapeutics
Chemical Modifications and Design Influence the Potency of Huntingtin Anti-Gene Oligonucleotides.
- 3 Feb 2023
- Nucleic acid therapeutics
Acknowledgment of Reviewers 2022
- 1 Feb 2023
- Nucleic Acid Therapeutics
Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.
- 28 Dec 2022
- Nucleic acid therapeutics
Compare Similar Journals with Nucleic Acid Therapeutics
Select Journals to Compare with Nucleic Acid Therapeutics
Total journals - 8
You can select up to 3 Journals at a time
International Journal of Molecular Sciences
Publisher: MDPI
Nucleic Acids Research
Publisher: OXFORD UNIV PRESS
Scientific Reports
Publisher: NATURE PORTFOLIO
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Molecular Therapy - Nucleic Acids
Publisher: CELL PRESS
Molecules
Publisher: MDPI
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Controlled Release
Publisher: ELSEVIER
0 Journals Selected to compare with
Nucleic Acid Therapeutics
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Nucleic Acid Therapeutics
How long has Nucleic Acid Therapeutics been actively publishing? 
Nucleic Acid Therapeutics has been in operation since 2011 till date.
What is the publishing frequency of Nucleic Acid Therapeutics?
Nucleic Acid Therapeutics published with a Bi-monthly frequency.
How many articles did Nucleic Acid Therapeutics publish last year?
In 2023, Nucleic Acid Therapeutics publsihed 5 articles.
What is the eISSN & pISSN for Nucleic Acid Therapeutics?
For Nucleic Acid Therapeutics, eISSN is 2159-3345 and pISSN is 2159-3337.
What is Citescore for Nucleic Acid Therapeutics?
Citescore for Nucleic Acid Therapeutics is 9.3.
What is SNIP score for Nucleic Acid Therapeutics?
SNIP score for Nucleic Acid Therapeutics is 1.19.
What is the SJR for Nucleic Acid Therapeutics?
SJR for Nucleic Acid Therapeutics is Q1.
Who is the publisher of Nucleic Acid Therapeutics?
MARY ANN LIEBERT, INC is the publisher of Nucleic Acid Therapeutics.
